共 13 条
[1]
Codner P(2017)Coronary stents in diabetic patients: state of the knowledge Curr Cardiol Rep 19 28-875 e861
[2]
Motivala A(2012)The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberte paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions Am Heart J 163 867-892
[3]
Grube E(2011)Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial Circulation 124 886-856
[4]
Kim WJ(2014)Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial JACC Cardiovasc Interv 7 849-294
[5]
Di Lorenzo E(2006)A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 286-365
[6]
Serruys PW(2000)Management of coronary artery disease: therapeutic options in patients with diabetes J Am Coll Cardiol 36 355-707
[7]
Hammoud T(2008)The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention J Am Coll Cardiol 51 701-undefined
[8]
Tanguay J-F(undefined)undefined undefined undefined undefined-undefined
[9]
Bourassa MG(undefined)undefined undefined undefined undefined-undefined
[10]
Kip KE(undefined)undefined undefined undefined undefined-undefined